Current work first investigated the potential role of EphB4 in tumor initiation first using genetic model of PTEN and EphB4 conditional deletion and subsequent studies of pharmacological inhibitor of the pathway in both tumor initiation and tumor progression. Here, PTEN is linked to neoplasm.